VREXNasdaqElectronic Components, NECUS GAAP · USD

Varex Imaging Corp

Varex Imaging Corp designs and manufactures X-ray imaging components and related systems used inside medical, security, and industrial inspection equipment. Its portfolio includes X-ray tubes, flat panel and photon counting detectors, high-voltage connectors, image-processing software, linear accelerators, and select stand-alone X-ray systems, with engineering, manufacturing, and service operations across North America, Europe, and Asia.

Revenue845m USD
+4.1 %y/y
Operating profit (EBIT)-27.8m USD
−186.6 %y/y
EBIT margin-3.3%
−7.2 ppy/y
Net income-70.3m USD
−44.1 %y/y
Free cash flow18.8m USD
−7.8 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

-20002004006008001,000m USD2020: 738 m USD2020: EBIT -34 m USD20202021: 818 m USD2021: EBIT 74 m USD20212022: 859 m USD2022: EBIT 88 m USD20222023: 893 m USD2023: EBIT 77 m USD20232024: 811 m USD2024: EBIT 32 m USD20242025: 845 m USD2025: EBIT -28 m USD2025845-28
RevenueOperating profit (EBIT)

Business

Share of revenue
Medical imaging components60 %

X-ray tubes, detectors, and related parts used in diagnostic imaging equipment.

Security inspection components15 %

X-ray sources and detectors used in security screening and inspection systems.

Industrial inspection components15 %

X-ray products used for non-destructive testing and quality inspection in manufacturing.

Software and accessories10 %

Image-processing software, connectors, and other supporting products sold with hardware.

Customers

Varex sells primarily to original equipment manufacturers that design its components into finished X-ray systems. Its customer base also includes system integrators, independent service companies, distributors, and some end users buying replacement parts. Demand is driven by medical imaging OEMs, security screening vendors, and industrial manufacturers that need specialized X-ray performance, reliability, and regulatory continuity.

Medical imaging OEMs

Buy X-ray tubes, detectors, and related components for CT, radiography, and other diagnostic systems; they value performance, reliability, and long-term supply.

Security inspection OEMs

Buy X-ray sources and detectors for screening systems used in airports, borders, and cargo inspection.

Industrial inspection OEMs and integrators

Buy components for non-destructive testing, defect detection, and measurement applications in manufacturing.

Replacement and service market

Buy spare parts, service components, and support products for installed X-ray systems over long equipment lives.

Strategy

Varex’s strategy centers on maintaining technology leadership in X-ray components through ongoing R&D, product performance improvements, and close collaboration with OEM customers. It also relies on manufacturing scale and long customer relationships to keep its components designed into installed systems and replacement channels. Growth opportunities are tied to new detector technologies, photon counting, and broader adoption of X-ray inspection in industrial applications.

Advance detector and tube technologyMedium term

New imaging performance helps win OEM design-ins and defend against in-house competition.

Grow industrial non-destructive testing applicationsMedium term

Industrial inspection broadens end markets beyond medical imaging and supports new use cases.

Protect OEM design-in relationshipsShort term

Once components are integrated into customer systems, switching costs and regulatory approvals support recurring demand.

Geography

Q2/2026

Varex sells into three reporting regions: the Americas, EMEA, and APAC, with final destination of products determining revenue geography. Its engineering, manufacturing, and service sites are spread across North America, Europe, and Asia, which supports proximity to OEM customers and global supply chains. The business is exposed to trade policy, import/export rules, and cross-border logistics because components and finished systems move through multiple jurisdictions.

Americas18 %
Asia Pacific18 %
United States16 %
Other countries (US filing)16 %
Europe, Middle East and Africa14 %
Japan9.7 %
China7.7 %

Share of the revenue the company reports by geography.

Risks

Varex is exposed to customer concentration, since a small number of OEMs account for a large share of revenue and many customers also compete with it. The business also faces trade-policy, tariff, and export-control risk because it operates globally and ships components across borders, while product defects, regulatory issues, and goodwill impairment can affect results and reported assets.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Customer concentration and OEM dependency1Trade and tariff disruption2China regulatory and policy risk3Goodwill impairment4Product liability and quality failure5
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Customer concentration and OEM dependencyImpact: HighLikelihood: High

    A limited number of large OEMs account for a substantial share of revenue, so order delays or losses can quickly reduce sales.

    ExposureCanonUnited Imaging HealthcareGESiemensRapiscan
  2. Trade and tariff disruptionImpact: HighLikelihood: High

    The company manufactures and sells across regions, so import/export restrictions and tariffs can raise costs or block shipments.

    ExposureAmericasEMEAAPAC
  3. China regulatory and policy riskImpact: HighLikelihood: High

    Medical products imported into China may be affected by investigations or policy changes, creating demand and compliance uncertainty.

    Exposure: China

  4. Goodwill impairmentImpact: HighLikelihood: High

    Acquired goodwill is tested for impairment and can be written down if forecasts, market value, or segment performance weaken.

  5. Product liability and quality failureImpact: MediumLikelihood: High

    X-ray components are embedded in regulated systems, so defects can lead to recalls, claims, or reputational damage.

Accounting

Judgemental items
Inventory valuation

Components are specialized and demand can shift, so management must estimate excess and obsolete inventory reserves.

Impact: Cost of revenues and gross margin

Goodwill impairment

The Medical reporting unit was impaired after lower forecasts and market-cap declines, showing sensitivity to assumptions.

Impact: Large non-cash operating charge

Intangible assets

Acquired technologies and customer relationships are amortized and may be impaired if expected cash flows weaken.

Impact: Operating income and asset values

Income taxes

Global operations create multi-jurisdiction tax estimates and potential valuation allowance judgments.

Impact: Tax expense and effective tax rate

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026

Varex Imaging Corp (VREX) Revenue, Earnings & Financials 2025 – Clarifo